Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Publication year range
1.
Bioprocess Biosyst Eng ; 47(8): 1321-1334, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38647679

ABSTRACT

Ultrasonic manufacturing has emerged as a promising eco-friendly approach to synthesize lipid-based nanocarriers for targeted drug delivery. This study presents the novel ultrasonic preparation of lipid nanocarriers loaded with Scutellaria barbata extract, repurposed for anticancer and antibacterial use. High-frequency ultrasonic waves enabled the precise self-assembly of DSPE-PEG, Span 40, and cholesterol to form nanocarriers encapsulating the therapeutic extract without the use of toxic solvents, exemplifying green nanotechnology. Leveraging the inherent anticancer and antibacterial properties of Scutellaria barbata, the study demonstrates that lipid encapsulation enhances the bioavailability and controlled release of the extract, which is vital for its therapeutic efficacy. Dynamic light scattering and transmission electron microscopy analyses confirmed the increase in size and successful encapsulation post-loading, along with an augmented negative zeta potential indicating enhanced stability. A high encapsulation efficiency of 91.93% was achieved, and in vitro assays revealed the loaded nanocarriers' optimized release kinetics and improved antimicrobial potency against Pseudomonas aeruginosa, compared to the free extract. The combination of ultrasonic synthesis and Scutellaria barbata in an eco-friendly manufacturing process not only advances green nanotechnology but also contributes to sustainable practices in pharmaceutical manufacturing. The data suggest that this innovative nanocarrier system could provide a robust platform for the development of nanotechnology-based therapeutics, enhancing drug delivery efficacy while aligning with environmental sustainability.


Subject(s)
Anti-Bacterial Agents , Antineoplastic Agents , Plant Extracts , Scutellaria , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Plant Extracts/chemistry , Scutellaria/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Drug Carriers/chemistry , Lipids/chemistry , Pseudomonas aeruginosa/drug effects , Nanoparticles/chemistry , Ultrasonic Waves , Humans , Green Chemistry Technology , Ultrasonics
2.
Nat Commun ; 10(1): 938, 2019 02 26.
Article in English | MEDLINE | ID: mdl-30808875

ABSTRACT

Little is known about enduring memory B cell (MBC) responses to Zika virus (ZIKV) and their relationship with circulating antibodies. Here we comprehensively assess MBC frequency and specificity alongside serum binding and neutralizing antibody responses to ZIKV ~2 weeks and ~8 months postinfection in 31 pediatric subjects with 0, 1 or >1 prior infections with the related dengue virus (DENV). ZIKV infection elicits a robust type-specific MBC response, and the majority of late convalescent anti-ZIKV serum neutralizing activity is attributable to ZIKV-specific antibodies. The number of prior DENV infections does not influence type-specific or cross-reactive MBC responses, although ZIKV has the highest cross-reactivity with DENV3. DENV cross-reactive MBCs expanded by ZIKV infection decline in number and proportion by late convalescence. Finally, ZIKV induces greater cross-reactivity in the MBC pool than in serum antibodies. Our data suggest immunity to DENV only modestly shapes breadth and magnitude of enduring ZIKV antibody responses.


Subject(s)
Antibodies, Viral/blood , B-Lymphocytes/immunology , Dengue/immunology , Zika Virus Infection/immunology , Adolescent , Antibodies, Neutralizing/blood , Child , Cross Reactions , Dengue/complications , Dengue Virus/classification , Dengue Virus/immunology , Female , Humans , Immunologic Memory , Male , Zika Virus/immunology , Zika Virus Infection/complications
3.
Environ Health Perspect ; 124(10): 1600-1607, 2016 Oct.
Article in English | MEDLINE | ID: mdl-26947464

ABSTRACT

BACKGROUND: Personal care products are a source of exposure to potentially endocrine-disrupting chemicals such as phthalates, parabens, triclosan, and benzophenone-3 (BP-3) for adolescent girls. METHODS: We enrolled 100 Latina girls in a youth-led, community-based participatory research intervention study to determine whether using personal care products whose labels stated they did not contain these chemicals for 3 days could lower urinary concentrations. Pre- and postintervention urine samples were analyzed for phthalate metabolites, parabens, triclosan, and BP-3 using high-performance liquid chromatography/tandem mass spectrometry. RESULTS: Urinary concentrations of mono-ethyl phthalate (MEP) decreased by 27.4% (95% CI: -39.3, -13.2) on average over the 3-day intervention; no significant changes were seen in urinary concentrations of mono-n-butyl phthalate (MnBP) and mono-isobutyl phthalate (MiBP). Methyl and propyl paraben concentrations decreased by 43.9% (95% CI: -61.3, -18.8) and 45.4% (95% CI: -63.7, -17.9), respectively. Unexpectedly, concentrations of ethyl and butyl paraben concentrations increased, although concentrations were low overall and not detected in almost half the samples. Triclosan concentrations decreased by 35.7% (95% CI: -53.3, -11.6), and BP-3 concentrations decreased by 36.0% (95% CI: -51.0, -16.4). DISCUSSION: This study demonstrates that techniques available to consumers, such as choosing personal care products that are labeled to be free of phthalates, parabens, triclosan, and BP-3, can reduce personal exposure to possible endocrine-disrupting chemicals. Involving youth in the design and implementation of the study was key to recruitment, retention, compliance, and acceptability of the intervention. CITATION: Harley KG, Kogut K, Madrigal DS, Cardenas M, Vera IA, Meza-Alfaro G, She J, Gavin Q, Zahedi R, Bradman A, Eskenazi B, Parra KL. 2016. Reducing phthalate, paraben, and phenol exposure from personal care products in adolescent girls: findings from the HERMOSA Intervention Study. Environ Health Perspect 124:1600-1607; http://dx.doi.org/10.1289/ehp.1510514.

4.
Int J Dermatol ; 51(2): 186-94, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22250629

ABSTRACT

BACKGROUND: Leprosy is a chronic infectious disease produced by Mycobacterium leprae. In 1997 Venezuela reached the goal of elimination of leprosy as a public health problem (according to the World Health Organization a prevalence rate of ≤ 1/10,000 inhabitants), but five states still had prevalence rates over that goal. For this study we selected Cojedes State, where prevalence rates remain over the elimination goal. OBJECTIVE: Evaluate the real leprosy situation in high-prevalence areas of Cojedes State. MATERIALS AND METHODS: Seven communities of Cojedes State were selected because they had the highest historic prevalence, as well as the highest prevalence in the year to be studied (1997). RESULTS: A rank correlation using Spearman's test comparing historical prevalence rates (1946-1996) and detection rates (1998-2004) gave a statistically significant P < 0.05 value. Diagnosed leprosy cases were as follows: age: 3.2% under 15 years old; sex: male/female rates between 60% and 91.66% males. The highest number of cases were paucibacillary forms: indeterminate leprosy (33.07%) and borderline tuberculoid leprosy (32.28%); tuberculoid leprosy (7.00%); and multibacillary cases (lepromatous leprosy, LL) were only 2.36%. Bacteriologically, 18.52 patients were M. leprae positive. At the moment of diagnosis, 96.6% showed no disabilities, 3.4% showed grade I disabilities, and there were no grade II or III disabilities. CONCLUSION: This study confirms that several communities in Cojedes State have extremely high leprosy rates.


Subject(s)
Endemic Diseases , Leprosy/epidemiology , Female , Humans , Leprosy/diagnosis , Male , Prevalence , Registries , Venezuela/epidemiology
5.
Quito; s.n; oct. 1995. 92 p. ilus, tab.
Thesis in Spanish | LILACS | ID: lil-206491

ABSTRACT

Se realizó un estudio longuitudinal descriptivo, en el que se comparó la carboxihemia medida con gasometría arterial vs los datos obtenidos con el monitor de gases respiratorios 5250 (RGM), en dos momentos anestésicos , en pacientes colecistectomizados, por vía laparoscópica, riesgo anestésico I-II-III, con saturación basal de oxígeno apropiada para la edad a 2800 m sobre el nivel del mar, mayores de 18 años con valores de HB mayores de 12.3 g/dl y sin patología pleuropulmonar, atendidos en el Hospital General de las Fuerzas Armadas de Quito. Se estableció la exactitud y la presión de los dos métodos en base a la relación lineal, sensibilidad y especificidad. Los resultados de la investigación demostraron que no existe linearidad entre la capnografía y la gasometría (r=0.34 con 95 por ciento de intervalo de confianza 0.12

Subject(s)
Humans , Carboxyhemoglobin , Cholecystectomy , Ecuador , Laparoscopy , Monitoring, Immunologic
SELECTION OF CITATIONS
SEARCH DETAIL